STOCK TITAN

Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Elanco Animal Health (ELAN) has released a groundbreaking report highlighting the widespread issue of canine itchiness in America. The study reveals that 90% of U.S. dogs experience itchiness, with 83% showing increased symptoms during allergy seasons. Pet owners typically wait 6 weeks before seeking veterinary care and spend an average of $173 more during allergy season on treatments. The report emphasizes the emotional and financial toll on pet owners, with 53% feeling judged and 75% feeling hopeless when treatments fail. The study also identifies America's "Itchiest Cities," with Memphis pet owners spending $548 annually on itch treatments compared to the national average of $302. Elanco promotes their new product Zenrelia (ilunocitinib tablets) as a once-daily, cost-effective solution for canine itch relief.
Elanco Animal Health (ELAN) ha pubblicato un rapporto innovativo che mette in luce il diffuso problema del prurito nei cani in America. Lo studio rivela che il 90% dei cani negli Stati Uniti soffre di prurito, con l'83% che manifesta sintomi peggiorati durante le stagioni allergiche. I proprietari di animali aspettano in media 6 settimane prima di rivolgersi al veterinario e spendono circa 173 dollari in più durante la stagione delle allergie per i trattamenti. Il rapporto sottolinea l'impatto emotivo e finanziario sui proprietari, con il 53% che si sente giudicato e il 75% che prova disperazione quando i trattamenti non funzionano. Lo studio identifica inoltre le "Città più pruriginose" d'America, con i proprietari di Memphis che spendono 548 dollari all'anno per i trattamenti contro il prurito, rispetto alla media nazionale di 302 dollari. Elanco promuove il suo nuovo prodotto Zenrelia (compresse di ilunocitinib) come soluzione efficace, conveniente e da assumere una volta al giorno per alleviare il prurito nei cani.
Elanco Animal Health (ELAN) ha publicado un informe innovador que destaca el problema generalizado del picor en perros en Estados Unidos. El estudio revela que el 90% de los perros en EE.UU. experimentan picor, con un 83% que muestra síntomas aumentados durante las temporadas de alergias. Los dueños de mascotas suelen esperar 6 semanas antes de buscar atención veterinaria y gastan un promedio de 173 dólares más durante la temporada de alergias en tratamientos. El informe enfatiza el impacto emocional y financiero en los dueños, con un 53% que se siente juzgado y un 75% que se siente desesperanzado cuando los tratamientos fallan. El estudio también identifica las "Ciudades con más picor" de América, donde los dueños de mascotas en Memphis gastan 548 dólares anuales en tratamientos para el picor, en comparación con el promedio nacional de 302 dólares. Elanco promociona su nuevo producto Zenrelia (tabletas de ilunocitinib) como una solución diaria, económica y efectiva para aliviar el picor en perros.
Elanco Animal Health(ELAN)는 미국 내 개들의 가려움증 문제를 강조하는 획기적인 보고서를 발표했습니다. 연구에 따르면 미국 개의 90%가 가려움을 경험하며, 83%는 알레르기 시즌에 증상이 악화되는 것으로 나타났습니다. 반려동물 주인들은 보통 수의사 진료를 받기까지 6주를 기다리며, 알레르기 시즌 동안 치료에 평균 173달러를 더 지출합니다. 이 보고서는 치료 실패 시 53%가 평가받는다고 느끼고 75%가 절망감을 느끼는 등 반려동물 주인들의 정서적·경제적 부담을 강조합니다. 또한 미국 내 '가려움증 심한 도시'를 밝혀냈으며, 멤피스의 반려동물 주인들은 연간 548달러를 가려움 치료에 쓰는 반면 전국 평균은 302달러입니다. Elanco는 새로운 제품 Zenrelia(일루노시티닙 정제)를 하루 한 번 복용하는 비용 효율적인 개 가려움 완화 솔루션으로 홍보합니다.
Elanco Animal Health (ELAN) a publié un rapport révolutionnaire mettant en lumière le problème généralisé des démangeaisons chez les chiens en Amérique. L'étude révèle que 90 % des chiens américains souffrent de démangeaisons, avec 83 % présentant des symptômes accrus durant les saisons allergiques. Les propriétaires d'animaux attendent généralement 6 semaines avant de consulter un vétérinaire et dépensent en moyenne 173 $ de plus en traitements pendant la saison des allergies. Le rapport souligne le poids émotionnel et financier pour les propriétaires, 53 % se sentant jugés et 75 % désespérés lorsque les traitements échouent. L'étude identifie également les « villes les plus démangeantes » d'Amérique, les propriétaires de Memphis dépensant 548 $ par an en traitements contre les démangeaisons, contre une moyenne nationale de 302 $. Elanco promeut son nouveau produit Zenrelia (comprimés d'ilunocitinib) comme une solution efficace, économique et à prise quotidienne pour soulager les démangeaisons canines.
Elanco Animal Health (ELAN) hat einen bahnbrechenden Bericht veröffentlicht, der das weitverbreitete Problem des Juckreizes bei Hunden in Amerika hervorhebt. Die Studie zeigt, dass 90 % der Hunde in den USA Juckreiz erleben, wobei 83 % während der Allergiesaisons verstärkte Symptome zeigen. Tierhalter warten im Durchschnitt 6 Wochen, bevor sie tierärztliche Hilfe suchen, und geben während der Allergiesaison durchschnittlich 173 US-Dollar mehr für Behandlungen aus. Der Bericht betont die emotionale und finanzielle Belastung der Tierhalter, wobei 53 % sich beurteilt fühlen und 75 % Hoffnungslosigkeit empfinden, wenn Behandlungen versagen. Die Studie identifiziert zudem die „juckendsten Städte“ Amerikas, wobei Tierhalter in Memphis jährlich 548 US-Dollar für Juckreizbehandlungen ausgeben, verglichen mit dem nationalen Durchschnitt von 302 US-Dollar. Elanco bewirbt sein neues Produkt Zenrelia (Ilunocitinib-Tabletten) als einmal täglich einzunehmende, kostengünstige Lösung zur Linderung von Juckreiz bei Hunden.
Positive
  • New product Zenrelia offers a once-daily, cost-effective treatment solution for a widespread market problem
  • High market potential with 90% of U.S. dogs experiencing itchiness
  • Strong veterinarian endorsement and adoption of the product
  • Product addresses a significant pain point in the pet care market with 75% of dog owners seeking more affordable options
Negative
  • Product requires dogs to be up to date on vaccinations before starting treatment
  • Contains a Boxed Warning regarding concurrent vaccine administration
  • Pet owners typically delay treatment for 6 weeks, potentially impacting early adoption
  • High competition in the market with pet owners using multiple treatments
  • The first-of-its-kind report includes results from multiple surveys revealing just how badly dogs around the country are itching for relief.
  • Data reveals that nearly 9 in 10 dogs in the U.S. are "itchy dogs" according to their pet owners, having experienced symptoms of itchiness at some point in the year.1
  • Allergy season makes itch worse, with 83% of pet owners saying that increased pollen levels affect their dog's itch.1
  • Veterinarians are the most trusted ally in solving dogs' itch, and the majority of veterinarians say that itchiness is the most frustrating issue they deal with.1
  • Leading veterinarians and canine dermatologists, including Drs. Joya Griffin, Andrew Rosenberg, and Tom Lewis, are pioneering the fight against itch, calling on other veterinarians to help America's itchy dogs find cost-effective itch relief and long-lasting solutions.

GREENFIELD, Ind., June 5, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today released a new report highlighting the significance of America's Itchy Dogs and the impact itch has on dogs, their owners, and veterinarians. The first-of-its-kind report includes findings from multiple surveys of pet owners, as well as veterinarians, and reveals startling details on how badly dogs around the country are itching for relief and cost-effective, long-lasting solutions. With Zenrelia™ (ilunocitinib tablets) now widely available as a once-daily, cost-effective solution, veterinarians and dog owners have another option to help dogs get back to normal.

"There are more itchy dogs out there than you might realize," said Dr. Jennifer Miller, veterinarian and canine dermatology expert at Elanco. "This report shows that nearly 9 in 10 U.S. dogs are 'itchy dogs,' according to their pet owners, experiencing symptoms of itchiness at any point throughout the year. Seasonal allergies make that worse, with more than 8 in 10 dog owners saying that their cities' pollen levels affect their dogs' itch levels. On average, pet owners say they're spending $173 more and using two additional treatments to treat their dogs' itch during allergy season; and they're desperate for a simple, cost-effective solution." 1

Veterinarians and Dog Owners Alike Are Frustrated by Itch
Itching is one of the top reasons dogs are brought to the veterinarian, and it's a frustrating issue for both dog owners and veterinarians alike.2 The new report finds that itchy dog owners on average wait 6 weeks after their dog has started showing symptoms of itch to take them to the veterinarian.2 Ninety percent of veterinarians say that itchy dog owners wait too long before bringing their dog, resulting in raw and infected skin and also an irritated dog owner who wants their dog to experience relief quickly.3 If a veterinarian can't scratch that itch quickly, pet owners will find one who can. Nearly 8 in 10 itchy dog owners who have switched veterinarians report switching after 3 visits or less.2 Switching veterinarians isn't the only extreme circumstance that owners of itchy dogs are willing to take – about half of dog owners say having an itchy dog tests their resolve to have a dog at all. Some say they'd be willing to move to a new city if it was going to help their dog's extreme itch.1

The report shows that a majority of itchy dog owners crave simplicity and long-lasting relief. When it comes to treating an itchy dog, the majority of dog owners want to give one pill a day compared to multiple pills per day.2 In 2024, 75% of dog owners said that they need more affordable options to stop their dogs' itch. 1

"These findings highlight the critical need for veterinarians to be an ally in the fight against itch and to deliver effective results by the second visit," says Dr. Joya Griffin, veterinarian and board-certified dermatologist at Animal Dermatology Clinic in Louisville. "Itching doesn't just affect the dog; it can have a significant impact on the whole family. Having the right tools is critical for alleviating the itch and discomfort both seasonally and year-around. I've recently started using Zenrelia in my clinic and have seen firsthand how this once-daily, cost-effective treatment can provide much needed relief during allergy season and for refractory patients who suffer year round."

Dogs should be up to date on vaccinations prior to starting Zenrelia. It's important to read the package insert, including the full Boxed Warning regarding concurrent vaccine administration, or speak with your veterinarian before use.

The data also revealed there are a lot of emotions tied to an itchy dog – 53%1 of itchy dog owners report feeling judged by someone in their community for having an itchy dog and 75% feel hopeless when their veterinarian is unable to treat their itchy dog.1

"As a veterinary dermatologist, I've seen the emotional toll having an itchy dog can take on pet owners. Many of my clients have invested significant time and resources on multiple treatment options that often times do not provide relief for their pet," said Dr. Andrew Rosenberg, veterinarian and President of the American College of Veterinary Dermatology (AVCD). "Now with Zenrelia, I have another great tool in my treatment toolbox that allows me to prescribe a simple, cost-effective solution that provides the relief both dogs and their owners have been craving."

After finding successful treatment for itchy dogs, veterinarians and pet owners have a stronger bond than ever. In fact, 84% of veterinarians say that dog owners are more likely to visit for other issues with their dog and 70% of dog owners refer other dog owners to their office.3

"I've seen how helping the dog find zen also increases the bond with my clients," said Dr. Tom Lewis, veterinarian and board-certified dermatologist at Dermatology Animals in Gilbert. "Often times, by the time the dog owner gets to me, they're just as frustrated as the dog is. Now, I know I have a treatment option that I can try that gets both dogs and their owners back to zen; that's why I'm encouraging other veterinarians to join us in becoming allies against itch."

The Highest Human Allergy Cities Have More Itchy Dogs
For dog owners and veterinarians who live in the highest human allergy cities in the country, they may be seeing more itchy dogs.1,4 In fact, 85% of dogs in the Allergy and Asthma Foundation's top U.S. allergy capitals experience itch during allergy season, compared to 79% of all U.S. dogs.

The deep dive into these cities, also appropriately called "America's Itchiest Cities," highlights some unique differences in each city and state. For example:1

  • Wichita, KS itchy dog owners are more likely than U.S. dog owners to feel financially burdened when they have to go to a veterinarian to treat their itchy dog.
  • New Orleans, LA has the itchiest dogs year-round.
  • Oklahoma City, OK itchy dog owners are on the hunt for the best treatment.
  • Tulsa, OK itchy dog owners feel the financial strain of trying different treatments more than U.S. dog owners in general.
  • Memphis, TN itchy dog owners are doing the most and spending the most, spending a whopping $548 year-round to treat their dogs' itchiness compared to $302 for U.S. dog owners.
  • Little Rock, AR itchy dog owners report fewer visits to their veterinarian but have tried just as many treatments.
  • Raleigh, NC itchy dog owners are the least judgmental of itchiness.
  • Richmond, VA itchy dog owners are going above and beyond, more likely to seek out a specialist.
  • Greenville, SC itchy dog owners are the most likely to feel compassionate when it comes to itch.
  • Greensboro, NC itchy dogs feel the itch even longer with an extended allergy season.

Dr. Emily Roberson, veterinarian at Animal Hospital of East Davie just outside of Greensboro, NC, says that she's seen a number of itchy dogs this year and has been relieved to have another treatment option. "Here in North Carolina, we're right in the thick of allergy season, and my clinic has seen an influx of itchy dogs. It's truly heartbreaking to see these pets so uncomfortable. That's why I'm thrilled to have Zenrelia as a treatment option to offer these itchy dogs, and their owners, much-needed comfort."

For additional information, resources, and to learn more about America's Itchy Dogs visit www.ItchyDogs.com.

*Drs. Griffin, Rosenberg, and Lewis are consultants for Elanco Animal Health.

ABOUT ELANCO
Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders and society as a whole. With 70 years of animal health heritage, we are committed to breaking boundaries and going beyond to help our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose™ sustainability pillars – all to advance the health of animals, people, the planet and our enterprise. Learn more at www.elanco.com

INDICATIONS
Zenrelia is a prescription medication used to control itching and inflammation associated with skin allergies for dogs over 12 months of age. 

IMPORTANT SAFETY INFORMATION
See package insert including the Boxed Warning. For full prescribing information speak with your veterinarian, call 1 888 545 5973 or visit www.elancolabels.com/us/zenrelia

WARNING: VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease from modified live virus vaccines and inadequate immune response to any vaccine. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Dogs should be monitored for the development of infections because Zenrelia may increase the chances of developing an infection. Neoplastic conditions (benign and malignant) were observed during clinical studies. The most common side effects were vomiting, diarrhea and tiredness. Zenrelia has not been tested in dogs used for breeding, pregnant, or lactating dogs and has not been evaluated in combination with glucocorticoids, cyclosporine, or other immune suppressive drugs. 

© 2025 Elanco or its affiliates: Zenrelia, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

PM-US-25-1076

1 Elanco Animal Health. Data on File
2 Elanco Animal Health. Data on File
3 Elanco Animal Health. Data on File
4 *Allergy Capital dog owners / dogs refers to all respondents living in one of the top 10 allergy DMAs: Wichita, KS; New Orleans, LA; Oklahoma City, OK; Tulsa, OK; Memphis, TN; Little Rock, AR; Raleigh, NC; Richmond, VA; Greenville, SC; Greensboro, NC

Investor Contact: Tiffany Kanaga (765) 740-0314 tiffany.kanaga@elancoah.com
Media Contact: Season Solorio (765) 316-0233 season.solorio@elancoah.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/elanco-releases-new-report-highlighting-the-significance-of-americas-itchy-dogs-and-the-need-for-itch-relief-302474271.html

SOURCE Elanco Animal Health

FAQ

What percentage of dogs in the US experience itchiness according to Elanco's (ELAN) new report?

According to Elanco's report, nearly 90% of dogs in the U.S. experience symptoms of itchiness at some point during the year.

How much do pet owners spend on treating dog itchiness during allergy season?

Pet owners spend an average of $173 more and use two additional treatments during allergy season compared to regular periods.

What is Elanco's (ELAN) new treatment for dog itchiness called?

Elanco's new treatment is called Zenrelia (ilunocitinib tablets), a once-daily solution for dog itch relief.

Which city spends the most on treating dog itchiness according to Elanco's report?

Memphis, TN pet owners spend the most, averaging $548 annually on treating dog itchiness compared to the national average of $302.

What are the main concerns for pet owners dealing with itchy dogs according to Elanco's study?

The study shows that 53% of owners feel judged for having an itchy dog, 75% feel hopeless when treatments fail, and many struggle with the financial burden of treatments.
Elanco Animal Health

NYSE:ELAN

ELAN Rankings

ELAN Latest News

ELAN Stock Data

6.66B
491.24M
0.88%
100.87%
2.92%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
GREENFIELD